share_log
Reuters ·  05/01 08:00

Editas Medicine Inc: Under Collaboration, Bristol Myers Squibb Has Opted Into 13 Different Programs Across 11 Gene Targets to Date

Editas Medicine Inc:在合作下,迄今为止,百时美施贵宝已选择了针对11个基因靶标的13种不同计划

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发